Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Menstrual migraine

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44364   clinical trials with a EudraCT protocol, of which   7388   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    11 result(s) found for: Menstrual migraine. Displaying page 1 of 1.
    EudraCT Number: 2010-019288-13 Sponsor Protocol Number: MK0974-065 Start Date*: 2010-06-24
    Sponsor Name:Merck, Sharp & Dohme B.V.
    Full Title: A Six Month Phase II/III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Telcagepant (MK-0974) for Prevention of Menstrually Relat...
    Medical condition: Migraine
    Disease: Version SOC Term Classification Code Term Level
    12.1 10027599 Migraine LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Completed) GB (Completed) SE (Completed) DE (Completed) FI (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2019-001081-15 Sponsor Protocol Number: APH204 Start Date*: 2019-06-25
    Sponsor Name:Asarina Pharma ApS
    Full Title: An exploratory phase II, randomised, double-blind, placebo-controlled, parallel-group study investigating the efficacy and safety of Sepranolone in women with menstrual migraine
    Medical condition: Menstrual migraine
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004852 10065540 Menstrual migraine LLT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed) FI (Completed)
    Trial results: View results
    EudraCT Number: 2009-010862-43 Sponsor Protocol Number: BGC20-1531-06 Start Date*: 2009-06-11
    Sponsor Name:BTG International Ltd
    Full Title: A multinational, multi-centre, randomised, double-blind, placebo-controlled, 3-way crossover study in migraine patients, treated with two doses of BGC20-1531 and placebo.
    Medical condition: Acute migraine
    Disease: Version SOC Term Classification Code Term Level
    9.1 10027599 Migraine LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2018-004096-12 Sponsor Protocol Number: WHAT!-RCT Start Date*: 2019-06-03
    Sponsor Name:LUMC
    Full Title: Open-label randomized controlled trial for the effects of continuous ethinylestradiol/levonorgestrel (30/150 μg/day) compared with vitamin E (400 IU/day) in the treatment of menstrually-related mig...
    Medical condition: Migraine
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029205 - Nervous system disorders 10032066 Other forms of migraine LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2004-001969-17 Sponsor Protocol Number: VML 251-3MRM02 Start Date*: 2005-01-10
    Sponsor Name:Vernalis Development Limited
    Full Title: A double-blind, placebo-controlled, parallel group study, with an open-label extension phase, to assess the efficacy, tolerability and safety of oral frovatriptan in the prevention of menstrually-r...
    Medical condition: Menstrually-Related Migraine (MRM)
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: FI (Completed) SE (Completed) DE (Completed) GB (Completed) IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-001335-30 Sponsor Protocol Number: N0S103325 Start Date*: 2005-12-07
    Sponsor Name:GlaxoSmithKline R&D
    Full Title: A Multicentre, Two-Part, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy,Tolerability and Pharmacokinetics of the iNOS Inhibitor GW274150 Administered up...
    Medical condition: Prophylaxis of migraine headache
    Disease: Version SOC Term Classification Code Term Level
    8.1 10058734 Migraine prophylaxis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) DK (Completed) BE (Completed) FI (Completed) IT (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2008-005392-10 Sponsor Protocol Number: CBGG492A2204 Start Date*: 2009-03-31
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A multi-centre, randomized, double-blind, parallel group, active and placebo controlled, Proof of Concept study in patients with acute migraine to assess the efficacy, safety and tolerability of si...
    Medical condition: Acute migraine
    Disease: Version SOC Term Classification Code Term Level
    9.1 10066635 Acute migraine LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2006-000799-33 Sponsor Protocol Number: 001 Start Date*: 2007-06-22
    Sponsor Name:Universitätsklinikum Essen
    Full Title: A Study of the efficacy and safety of Rizatriptan 10 mg PRD in the treatment of acute migraine in patients with non satisfactory response to previous pharmacologic treatment
    Medical condition: acute migraine
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-006773-92 Sponsor Protocol Number: FARM6TT8SP Start Date*: 2008-07-23
    Sponsor Name:UNIVERSITA' DEGLI STUDI DI PERUGIA
    Full Title: Sodium Valproate in the treatment of medication overuse headache: a controlled randomized clinical trial.
    Medical condition: medication overuse headache
    Disease: Version SOC Term Classification Code Term Level
    9.1 10013753 Drug withdrawal headache LLT
    9.1 10019231 Headaches HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-002563-18 Sponsor Protocol Number: PC_RSV_003 Start Date*: 2017-10-09
    Sponsor Name:Pulmocide Ltd
    Full Title: A single-blind, placebo controlled, randomised study to evaluate antiviral activity and safety and pharmacokinetics of inhaled PC786 against respiratory syncytial virus (RSV) in healthy adult subje...
    Medical condition: Human Respiratory Syncytial Virus (RSV)
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000109842 10070358 Human respiratory syncytial virus test positive LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2018-001275-21 Sponsor Protocol Number: TAK-906-2002 Start Date*: 2019-06-18
    Sponsor Name:Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
    Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2b Study to Evaluate the Efficacy and Safety of Twice-Daily Oral Administration of a Peripherally Acting Dopamine ...
    Medical condition: Gastroparesis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10017947 - Gastrointestinal disorders 10018043 Gastroparesis LLT
    20.1 10017947 - Gastrointestinal disorders 10051153 Diabetic gastroparesis PT
    20.1 10017947 - Gastrointestinal disorders 10021227 Idiopathic gastroparesis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed) PL (Completed) IT (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri Oct 31 07:34:13 CET 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA